Medicines Co. Licenses Rights to Cholesterol Drug

The drug inhibits the protein PCSK9 and might one day be used to treat millions of people whose cholesterol is not lowered enough by common statins, such as Lipitor.

Source: NYT Health - February 4, 2013 Category: Consumer Health News Authors: By ANDREW POLLACK Tags: Biogen Idec Inc BIIB NASDAQ Cambridge (Mass) Pfizer Inc PFE NYSE Drugs (Pharmaceuticals) Roche Holding A G RHHBY Other OTC Sanofi SA SNY NYSE Cholesterol Amgen Inc AMGN NASDAQ Alnylam Pharmaceuticals Inc ALNY NASDAQ Regeneron Pharmaceuti Source Type: news